Form D · Other
Boulder Botanicals & Biosciences Laboratories, Inc.
Golden, CO · CIK 0001762755
Offering snapshot reported Feb 19, 2019 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Feb 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2019 | Initial | $500,000 | No comparison | 25 | SEC filing |
| Dec 28, 2018 | Initial | $4,233,435 | No comparison | 66 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333074
Source: Form D, filed Feb 19, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sanjay Arora | Executive |
| Alain Castro | Director |
| Robert Di Marco | Director, Executive |
| Argelia Lachance | Director, Executive |
| John White, Jr. | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1150 Catamount Drive
Golden, CO, 80403
Golden, CO, 80403